Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Head and Neck Pathology
Erschienen in: Head and Neck Pathology 1/2022

21.03.2022 | Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: The Neck and Lymph Nodes, Metastasis, and Melanocytic Tumors

verfasst von: Juan C. Hernandez-Prera

Erschienen in: Head and Neck Pathology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

The changes made in the fifth edition of the WHO Classification of Head and Neck Tumors demonstrate the recent diagnostic, histopathological, and molecular advances in the field, and this updated information will hopefully lead to improved and standardized tumor subtyping. This review summarizes the changes related tumors and tumor-like lesions of the neck and lymph nodes (Chapter 11), metastasis to the head and neck region (Chapter 15), and melanocytic tumors (Chapter 10).
Literatur
1.
Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128(7):751–8.PubMedCrossRef
2.
de Visscher JG, van der Wal KG, de Vogel P. The plunging ranula. Pathogenesis, diagnosis and management. J Craniomaxillofac Surg. 1989;17(4):182–5.PubMedCrossRef
3.
Jain P. Plunging ranulas and prevalence of the “tail sign” in 126 consecutive cases. J Ultrasound Med. 2020;39(2):273–8.PubMedCrossRef
4.
Zhao YF, Jia Y, Chen XM, Zhang WF. Clinical review of 580 ranulas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(3):281–7.PubMedCrossRef
5.
Acierno SP, Waldhausen JH. Congenital cervical cysts, sinuses and fistulae. Otolaryngol Clin N Am. 2007;40(1):161–76, vii–viii.
6.
Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, et al. Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck. 2008;30(7):898–903.PubMedCrossRef
7.
Pai RK, Erickson J, Pourmand N, Kong CS. p16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx. Cancer. 2009;117(2):108–19.PubMed
8.
Cao D, Begum S, Ali SZ, Westra WH. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Hum Pathol. 2010;41(4):535–9.PubMedCrossRef
9.
Bishop JA, Westra WH. Ciliated HPV-related carcinoma: a well-differentiated form of head and neck carcinoma that can be mistaken for a benign cyst. Am J Surg Pathol. 2015;39(11):1591–5.PubMedPubMedCentralCrossRef
10.
Sivars L, Landin D, Rizzo M, Haeggblom L, Bersani C, Munck-Wikland E, et al. Human papillomavirus (HPV) is absent in branchial cleft cysts of the neck distinguishing them from HPV positive cystic metastasis. Acta Otolaryngol. 2018;138(9):855–8.PubMedCrossRef
11.
Lewis JS Jr, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142(5):559–97.PubMedCrossRef
12.
Bradley PT, Bradley PJ. Branchial cleft cyst carcinoma: fact or fiction? Curr Opin Otolaryngol Head Neck Surg. 2013;21(2):118–23.PubMedCrossRef
13.
Chadburn A, Abdul-Nabi AM, Teruya BS, Lo AA. Lymphoid proliferations associated with human immunodeficiency virus infection. Arch Pathol Lab Med. 2013;137(3):360–70.PubMedCrossRef
14.
Chadburn A, Metroka C, Mouradian J. Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex. Hum Pathol. 1989;20(6):579–87.PubMedCrossRef
15.
Ioachim HL, Ryan JR, Blaugrund SM. Salivary gland lymph nodes. The site of lymphadenopathies and lymphomas associated with human immunodeficiency virus infection. Arch Pathol Lab Med. 1988;112(12):1224–8.PubMed
16.
Labouyrie E, Merlio JP, Beylot-Barry M, Delord B, Vergier B, Brossard G, et al. Human immunodeficiency virus type 1 replication within cystic lymphoepithelial lesion of the salivary gland. Am J Clin Pathol. 1993;100(1):41–6.PubMedCrossRef
17.
Ryan JR, Ioachim HL, Marmer J, Loubeau JM. Acquired immune deficiency syndrome--related lymphadenopathies presenting in the salivary gland lymph nodes. Arch Otolaryngol (Chicago, IL: 1960). 1985;111(8):554–6.
18.
Hernandez-Prera JC. Sialadenitis of the major salivary glands: a tumor-like lesion of various etiologies and morphological appearances. AJSP Rev Rep. 2020;25:255–64.
19.
20.
21.
Rohof D, Honings J, Theunisse HJ, Schutte HW, van den Hoogen FJ, van den Broek GB, et al. Recurrences after thyroglossal duct cyst surgery: results in 207 consecutive cases and review of the literature. Head Neck. 2015;37(12):1699–704.PubMedCrossRef
22.
Pryor SG, Lewis JE, Weaver AL, Orvidas LJ. Pediatric dermoid cysts of the head and neck. Otolaryngol Head Neck Surg. 2005;132(6):938–42.PubMedCrossRef
23.
Orozco-Covarrubias L, Lara-Carpio R, Saez-De-Ocariz M, Duran-McKinster C, Palacios-Lopez C, Ruiz-Maldonado R. Dermoid cysts: a report of 75 pediatric patients. Pediatr Dermatol. 2013;30(6):706–11.PubMedCrossRef
24.
Hanikeri M, Waterhouse N, Kirkpatrick N, Peterson D, Macleod I. The management of midline transcranial nasal dermoid sinus cysts. Br J Plast Surg. 2005;58(8):1043–50.PubMedCrossRef
25.
26.
Smith PS, McClure J. Unusual subcutaneous mixed tumour exhibiting adipose, fibroblastic, and epithelial components. J Clin Pathol. 1982;35(10):1074–7.PubMedPubMedCentralCrossRef
27.
Rosai J, Limas C, Husband EM. Ectopic hamartomatous thymoma. A distinctive benign lesion of lower neck. Am J Surg Pathol. 1984;8(7):501–13.PubMedCrossRef
28.
Fetsch JF, Laskin WB, Michal M, Remotti F, Heffner D, Ellis G, et al. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. Am J Surg Pathol. 2004;28(10):1360–70.PubMedCrossRef
29.
Weissferdt A, Kalhor N, Petersson F, Moran CA. Ectopic hamartomatous thymoma—new insights into a challenging entity: a clinicopathologic and immunohistochemical study of 9 cases. Am J Surg Pathol. 2016;40(11):1571–6.PubMedCrossRef
30.
Sato K, Thompson LDR, Miyai K, Kono T, Tsuda H. Ectopic hamartomatous thymoma: a review of the literature with report of new cases and proposal of a new name: biphenotypic branchioma. Head Neck Pathol. 2018;12(2):202–9.PubMedCrossRef
31.
Kazakov DV, Mukensnabl P, Hes O, Michal M. ‘Ectopic’ ectopic hamartomatous thymoma. Histopathology. 2004;45(2):202–4.PubMedCrossRef
32.
Liang PI, Li CF, Sato Y, Lee VK, Bahrami A, Chuang SS. Ectopic hamartomatous thymoma is distinct from lipomatous pleomorphic adenoma in lacking PLAG1 aberration. Histopathology. 2013;62(3):518–22.PubMedCrossRef
33.
Saeed IT, Fletcher CD. Ectopic hamartomatous thymoma containing myoid cells. Histopathology. 1990;17(6):572–4.PubMedCrossRef
34.
Thompson LDR, Gagan J, Washington A, Miller RT, Bishop JA. Biphenotypic branchioma: a better name than ectopic hamartomatous thymoma for a neoplasm with HRAS mutation. Head Neck Pathol. 2020;14(4):884–8.PubMedPubMedCentralCrossRef
35.
Hui M, Uppin SG, Paul TR, Jena S, Patil RS, Ranganath R. Need for re-classifying the rare condition of ectopic hamartomatous thymoma based on tumor analysis. Arch Otorhinolaryngol Head Neck Surg (AOHNS). 2020;4(3):1.
36.
Weinreb I, O’Malley F, Ghazarian D. Ectopic hamartomatous thymoma: a case demonstrating skin adnexal differentiation with positivity for epithelial membrane antigen, androgen receptors, and BRST-2 by immunohistochemistry. Hum Pathol. 2007;38(7):1092–5.PubMedCrossRef
37.
Michal M, Neubauer L. Carcinoma arising in ectopic hamartomatous thymoma. A previously unpublished occurrence. Report of two cases. Zentralbl Pathol. 1993;139(4–5):381–6.PubMed
38.
Thompson LDR, Herrera HB, Lau SK. Thyroglossal duct cyst carcinomas: a clinicopathologic series of 22 cases with staging recommendations. Head Neck Pathol. 2017;11(2):175–85.PubMedCrossRef
39.
Pradhan R, Agarwal A, Lombardi CP, Raffaelli M. Applied embryology of the thyroid and parathyroid glands. In Surgery of the Thyroid and Parathyroid Glands. Elsevier; 2021. p. 15–25.e4.
40.
Rayess HM, Monk I, Svider PF, Gupta A, Raza SN, Lin HS. Thyroglossal duct cyst carcinoma: a systematic review of clinical features and outcomes. Otolaryngol Head Neck Surg. 2017;156(5):794–802.PubMedCrossRef
41.
Rossi ED, Martini M, Straccia P, Cocomazzi A, Pennacchia I, Revelli L, et al. Thyroglossal duct cyst cancer most likely arises from a thyroid gland remnant. Virchows Arch. 2014;465(1):67–72.PubMedCrossRef
42.
Stein T, Murugan P, Li F, El Hag MI. Can medullary thyroid carcinoma arise in thyroglossal duct cysts? A search for parafollicular C-cells in 41 resected cases. Head Neck Pathol. 2018;12(1):71–4.PubMedCrossRef
43.
Som P, Miletich I. The embryology of the salivary glands: an update. Neurographics. 2015;5(4):167–77.CrossRef
44.
Kurian EM, Miller R, McLean-Holden AL, Oliai BR, Bishop JA. Low molecular weight cytokeratin immunostaining for extrafollicular reticulum cells is an effective means of separating salivary gland tumor-associated lymphoid proliferation from true lymph node involvement. Head Neck Pathol. 2020;14(3):593–7.PubMedCrossRef
45.
Ferlito A, Bertino G, Rinaldo A, Mannarà GM, Devaney KO. A review of heterotopia and associated salivary gland neoplasms of the head and neck. J Laryngol Otol. 1999;113(4):299–303.PubMedCrossRef
46.
Daniel E, McGuirt WF Sr. Neck masses secondary to heterotopic salivary gland tissue: a 25-year experience. Am J Otolaryngol. 2005;26(2):96–100.PubMedCrossRef
47.
Rooper LM, Thompson LDR, Gagan J, Oliai BR, Weinreb I, Bishop JA. Salivary intraductal carcinoma arising within intraparotid lymph node: a report of 4 cases with identification of a novel STRN-ALK fusion. Head Neck Pathol. 2021;15(1):179–85.PubMedCrossRef
48.
Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suárez C, Kowalski LP, et al. Metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary cancer: management in the HPV era. Front Oncol. 2020;10:593164.PubMedPubMedCentralCrossRef
49.
Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol. 2000;55(2):121–9.PubMedCrossRef
50.
Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck. 2008;30(1):28–34.PubMedCrossRef
51.
Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, et al. Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. J Clin Oncol. 2018;36(31):3152–61.PubMedCrossRef
52.
Nakao K, Yuge T, Mochiki M, Nibu K, Sugasawa M. Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(3):338–40.PubMedCrossRef
53.
Singhi AD, Stelow EB, Mills SE, Westra WH. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34(6):800–5.PubMedCrossRef
54.
Fujimoto M, Matsuzaki I, Takahashi Y, Iwahashi Y, Warigaya K, Kojima F, et al. High-risk human papillomavirus E6/E7 mRNA is rarely detected in nonanogenital cutaneous squamous cell carcinoma: an RNA in situ hybridization-based tissue microarray study. Am J Dermatopathol. 2019;41(3):205–10.PubMedCrossRef
55.
56.
Mueller SA, Gauthier MA, Ashford B, Gupta R, Gayevskiy V, Ch’ng S, et al. Mutational patterns in metastatic cutaneous squamous cell carcinoma. J Invest Dermatol. 2019;139(7):1449–58.e1.
57.
Donizy P, Wróblewska JP, Dias-Santagata D, Woznica K, Biecek P, Mochel MC, et al. Merkel cell carcinoma of unknown primary: immunohistochemical and molecular analyses reveal distinct UV-signature/MCPyV-negative and high immunogenicity/MCPyV-positive profiles. Cancers (Basel). 2021;13(7):1621.CrossRef
58.
Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770–86.PubMedPubMedCentralCrossRef
59.
60.
Michal M, Skálová A, Simpson RH, Raslan WF, Curík R, Leivo I, et al. Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology. 1999;35(6):495–501.PubMedCrossRef
61.
62.
63.
Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol. 2003;27(5):594–611.PubMedCrossRef
64.
Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol. 2001;25(6):782–7.PubMedCrossRef
65.
Xu X, Palsgrove D, Kurian E, Yan S, Oliai BR, Bishop JA. Variable expression of S100 protein in sinonasal malignant mucosal melanoma: a potential diagnostic pitfall. Head Neck Pathol. 2020;14(4):929–35.PubMedPubMedCentralCrossRef
66.
Nassar KW, Tan AC. The mutational landscape of mucosal melanoma. Semin Cancer Biol. 2020;61:139–48.PubMedCrossRef
67.
Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, et al. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res. 2017;27(3):189–99.PubMedPubMedCentralCrossRef
68.
Zhou Z, Gong Q, Wang Y, Li M, Wang L, Ding H, et al. The biological function and clinical significance of SF3B1 mutations in cancer. Biomark Res. 2020;8(1):38.PubMedPubMedCentralCrossRef
Metadaten
Titel
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: The Neck and Lymph Nodes, Metastasis, and Melanocytic Tumors
verfasst von
Juan C. Hernandez-Prera
Publikationsdatum
21.03.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-022-01433-w

Weitere Artikel der Ausgabe 1/2022

Head and Neck Pathology 1/2022 Zur Ausgabe

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base

Sine qua non Radiology-Pathology

Kimura Disease: A Rare and Difficult to Diagnose Entity

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear

Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 20, 2022, Los Angeles, CA

Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview

Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 20, 2022, Los Angeles, CA

Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022. Emerging Bone and Soft Tissue Neoplasms in the Head and Neck Region

Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 20, 2022, Los Angeles, CA

Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …